$226 Thousand is the total value of UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's 19 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 300.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BBRE | Buy | JPM BETABLDRS MSCI US REITetfs | $206,069 | -4.7% | 2,649,388 | +3.5% | 91.27% | +9.2% |
| New | SPECTRAL AI INC | $1,709 | – | 665,858 | +100.0% | 0.76% | – | |
| NVDA | Buy | NVIDIA CORP | $572 | +18966.7% | 1,315 | +18685.7% | 0.25% | +25200.0% |
| ADSK | New | AUTODESK INC | $11 | – | 51 | +100.0% | 0.01% | – |
| GOOGL | New | ALPHABET INC | $10 | – | 76 | +100.0% | 0.00% | – |
| AAPL | Buy | APPLE INC | $10 | +400.0% | 56 | +409.1% | 0.00% | +300.0% |
| MSFT | New | MICROSOFT CORP | $10 | – | 33 | +100.0% | 0.00% | – |
| MGK | New | VANGUARD MEGA CAP GROWTH INDEX FUNDetfs | $10 | – | 44 | +100.0% | 0.00% | – |
| VOO | New | VANGUARD 500 INDEX FUNDetfs | $10 | – | 25 | +100.0% | 0.00% | – |
| VOT | New | VANGUARD MID-CAP GROWTH INDEX FUNDetfs | $10 | – | 52 | +100.0% | 0.00% | – |
| VBK | New | VANGUARD SMALL-CAP GROWTH ETF | $10 | – | 48 | +100.0% | 0.00% | – |
| BR | New | BROADRIDGE FINANCIAL SOLUTIONS | $3 | – | 14 | +100.0% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-09
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| TEXAS INSTRUMENTS INC | 41 | Q3 2023 | 31.2% |
| PORTLAND GENERAL ELECTRIC CO | 38 | Q3 2023 | 0.0% |
| LEXICON PHARMACEUTICALS INC | 33 | Q3 2023 | 1.7% |
| AEGLEA BIOTHERAPEUTICS INC | 27 | Q2 2023 | 11.0% |
| APOLLO ENDOSURGERY INC | 24 | Q1 2023 | 5.6% |
| PLX PHARMA INC | 23 | Q1 2023 | 1.7% |
| VANGUARD MSCI EMERGING MKTS | 22 | Q2 2019 | 10.3% |
| VANGUARD ENERGY ETF | 22 | Q2 2019 | 8.7% |
| VANGUARD S&P 500 ETF | 21 | Q3 2023 | 11.8% |
| VANGUARD MSCI EAFE ETF | 20 | Q2 2019 | 13.1% |
View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Taysha Gene Therapies, Inc. | September 24, 2021 | 1,156,255 | 3.0% |
| ZIOPHARM ONCOLOGY INC | February 12, 2016 | 9 | 0.0% |
View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-06-12 |
| 4 | 2024-06-07 |
| 4/A | 2024-05-14 |
| 4 | 2024-05-01 |
| 3 | 2024-04-30 |
| 13F-HR | 2024-04-30 |
| 144 | 2024-04-29 |
| SC 13G | 2024-03-05 |
| 13F-HR | 2024-02-28 |
| SC 13G | 2024-02-14 |
View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.